Feed Insights Top Reports Pricing

⌘K

08:04:33·707d

ANALYSTRatingvia Quantisnow

Riskified downgraded by Goldman

ByQuantisnow·Wall Street's wire, on your screen.

RSKD· Riskified Ltd.

Real Estate

Plus alert sent

Quantisnow Plus members were alerted at 08:04:34 ET - 1.8s after publication.

Sign up for Plus

Free Quantisnow account

Get notified the moment RSKD files

Real-time alerts on SEC filings, FDA approvals, analyst ratings, insider trades, and press releases. Follow any ticker. No credit card.

Sign up free Log in

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RSKD (Riskified Ltd.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Director Shachar Erez sold $1,147,415 worth of Class A Ordinary Shares (231,124 units at $4.96) (SEC Form 4)
SEC Form 144 filed by Riskified Ltd.
Director Shachar Erez converted options into 500,000 units of Class A Ordinary Shares and sold $937,181 worth of Class A Ordinary Shares (191,224 units at $4.90) (SEC Form 4)
SEC Form 144 filed by Riskified Ltd.
Director Shachar Erez sold $1,176,730 worth of Class A Ordinary Shares (240,612 units at $4.89) (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022